Lipoprotein(a) assembly: Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 12, 1996, Pages 1559-1567

  Gabel, Brent R ^a   May, Lorraine F ^a   Marcovina, Santica M ^b   Koschinsky, Marlys L ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

apolipoprotein(a); assembly; kringles; lipoprotein(a)

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A;

ARTICLE; DISULFIDE BOND; GENETIC RECOMBINATION; HUMAN; IMMUNOBLOTTING; KRINGLE DOMAIN; LIPOPROTEIN SYNTHESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN LIPID INTERACTION; SITE DIRECTED MUTAGENESIS;

EID: 0030454223     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.12.1559     Document Type: Article

References (35)

1. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 1986; 256:2540-2544.
2. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 1986;74:758-765.
3. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis E, Abolafia JM, Lippel K, Levy RI. Lipoprotein(a) levels and risk of coronary heart disease in men. JAMA. 1994;271:999-1003.
4. Zenker G, Koltringer P, Bone G, Niederkorn K, Pfeiffer, K, Jurgens, G. Lipoprotein(a) is a strong indicator for cerebrovascular disease. Stroke. 1986;17:942-945.
5. McLean JW, Tomlinson JE, Kuang W, Eaton DL, Chen E, Fless G, Scanu A, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;330:132-137.
6. van der Hoek YY, Wittekoek ME, Beisiegel U, Kastelein JJP, Koschinsky ML. The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Hum Mol Genet. 1993;2:361-366.
7. Lackner C, Cohen JC, Hobbs HH. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet. 1993;2:933-940.
8. Hervio L, Chapman MJ, Thillet J, Loyah S, Angles-Cano E. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis? Blood. 1993;82:392-397.
9. Harpel PC, Gordon BR, Parker TS. Plasmin catalyzes binding of lipoprotein(a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci U S A. 1989;86:3847-3851.
10. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding and plasminogen activation. Arteriosclerosis. 1990;10: 240-245.
11. Rouy D, Koschinsky ML, Fleury V, Chapman J, Anglés-Cano E. The binding of human recombinant apolipoprotein(a) and plasminogen to fibrin surfaces. Biochemistry. 1992;3:6333-6339.
12. Koschinsky ML, Côté GP, Gabel B, van der Hoek YY. Identification of the cysteine residue in apolipoprotein(a) which mediates extracellular coupling with apolipoproteinB-100. J Biol Chem. 1993;268: 19819-19825.
13. 4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc Natl Acad Sci U S A. 1993;90:11643-11647.
14. Frank S, Durovic S, Kostner GM. Structural requirements of apo-a for the lipoprotein-a assembly. Biochem J. 1994;304:27-30.
15. Ernst A, Helmhold M, Brunner C, Petho-Schramm P, Armstrong VW, Muller H-J. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a). J Biol Chem. 1994;270:6227-6234.
16. Chiesa G, Hobbs HH, Koschinsky ML, Lawn RM, Maika SD, Hammer RE. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J Biol Chem. 1992;267:24369-24374.
17. Trieu VN, McConathy WJ. A two-step model for lipoprotein(a) formation. J Biol Chem. 1995;270:15471-15474.
18. Koschinsky ML, Tomlinson JE, Zioncheck TF, Schwartz K, Eaton DL, Lawn RM. Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry. 1991;30:5044-5051.
19. Gabel B, Yao Z, McLeod RS, Young SG, Koschinsky ML. Carboxyl-terminal truncation of apolipoproteinB-100 inhibits lipoprotein(a) particle formation. FEBS Lett. 1994;350:77-81.
20. Sangrar W, Marcovina SM, Koschinsky ML. Expression and characterization of apolipoprotein kringle IV types 1, 2 and 10 in mammalian cells. Protein Eng. 1994;7:723-731.
21. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977;36:59-77.
22. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus IV DNA. Virology. 1973;52:456-467.
23. German C, Padmanahban R, Howard B. High efficiency DNA-mediated transformation of primate cells. Science. 1983;221: 551-553.
24. Havel RJ, Eder HA, Bragdon JD. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
25. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem. 1995;41: 246-255.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
27. Wong WLT, Eaton DL, Berloui A, Fendly B, Hass PE. A monoclonal-antibody-based enzyme-linked immunosorbent assay of lipoprotein(a). Clin Chem. 1990;36:192-197.
28. Wu TP, Padmanabhan K, Tulinsky A, Mulichak AM. The refined structure of the ∈-aminocaproic acid complex of human plasminogen kringle 4. Biochemistry. 1991;30:10589-10594.
29. Utermann G, Kraft HG, Menzel HJ, Hopferwieser T, Seitz C. Genetics of the quantitative Lp(a) lipoprotein trait: relation of Lp(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations. Hum Genet. 1993;78:41-46.
30. Bas Leerink C, Duif PF, Gimpel JA, Kortlandt W, Bouma BN, van Rijn HJ. Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation. Thromb Haemost. 1992;68:185-188.
31. Ye SQ, Trieu VN, Stiers DL, McConathy WJ. Interactions of low density lipoprotein, and other apolipoproteinB-containing lipoproteins with lipoprotein(a). J Biol Chem. 1988;263:6337-6343.
32. Trieu VN, McConathy WJ. Lipoprotein(a) binding to other apolipoprotein B containing lipoproteins. Biochemistry. 1990;29: 5919-5924.
33. Frank S, Durovic S, Kostner K, Kostner GM. Inhibitors for the m vitro assembly of Lp(a). Arterioscler Thromb Vasc Biol. 1995;15: 1774-1780.
34. Petros AM, Ramesh V, Llinas M. 1H NMR studies of aliphatic ligand binding to human plasminogen kringle 4. Biochemistry. 1989;28: 1368-1376.
35. LoGrasso PV, Cornell-Kennon S, Boettcher BR. Cloning, expression and characterization of human apolipoprotein(a) kringle IV37. J Biol Chem. 1994;269:21820-21827.